Cutting-Edge Technology AI VIVO utilizes advanced tech such as particles.js, Flickity, and RSS, indicating a strong technological infrastructure that can appeal to innovative-minded clients seeking modern solutions.
Niche Market Positioning Specializing in designing AI systems for OrganoMaps in biotechnology research, AI VIVO targets a specific niche within the industry that can attract clients looking for organizations with expertise in this unique field.
Competitive Analysis Insights Comparing with similar companies like Atomwise and Eagle Genomics, AI VIVO's revenue range and employee size position it favorably for collaboration with mid-sized firms in the biotech space.
Strategic Location Advantage Located in Cambridge, a renowned hub for biotech research, AI VIVO can leverage its proximity to cutting-edge research institutions to establish partnerships and collaborations with key players in the industry.
Innovative Medicine Development Through OrganoMaps that link disease biology and treatment interventions, AI VIVO fosters the creation of novel medicines, presenting an opportunity for partnerships with pharmaceutical companies seeking groundbreaking therapeutic approaches.
240
$50M$100M
54$10M
54$10M$50M
4$10M
51$10M$50M
104$10M$50M
140$10M$50MAI VIVO uses 8 technology products and services including particles.js, Flickity, OWL Carousel, and more. Explore AI VIVO 's tech stack below.
| AI VIVO Email Formats | Percentage |
| First@aivivo.co | 25% |
| First.Last@aivivo.co | 25% |
| Last@aivivo.co | 25% |
| FirstLast@aivivo.co | 25% |
Biotechnology ResearchEngland, United Kingdom11-50 Employees
We design artificial intelligence systems and generate multi-modal omics data to build OrganoMaps. OrganoMaps link disease biology and treatment interventions at the organ level to develop novel medicines for patients in need.
Company Overview
Funding & FinancialsAI VIVO 's revenue is in the range of $10M
Funding & FinancialsAI VIVO 's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com